Elevated levels of Thymidine kinase 1 peptide in serum from patients with breast cancer

Upsala Journal of Medical Sciences

Volumn 114, Issue 2, 2009, Pages 116-120

  Carlsson, Lena ^a   Larsson, Anders ^a   Lindman, Henrik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibodies; Breast cancer; Immunological sandwich assay; Thymidine kinase

Indexed keywords

PEPTIDE FRAGMENT; THYMIDINE KINASE; THYMIDINE KINASE 1; TUMOR MARKER;

ARTICLE; BLOOD; BREAST TUMOR; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FEMALE; HUMAN; ROC CURVE; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PEPTIDE FRAGMENTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; THYMIDINE KINASE; TUMOR MARKERS, BIOLOGICAL;

EID: 67650569503     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009730802688835     Document Type: Article

References (24)

1. Hu CM, Chang ZF. Mitotic control of dTTP pool: a necessity or coincidence? J Biomed Sci. 2007;14:491-497
2. Al-Madhoun AS, Tjarks W, Eriksson S. The role of thymidine kinases in the activation of pyrimidine nucleoside analogues. Mini Rev Med Chem. 2004;4:341-350
3. Wu C, Yang R, Zhou J, Bao S, Zou L, Zhang P, et al. Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1. J Immunol Methods. 2003;277:157-169
4. Gowda A, Byrd JC. Use of prognostic factors in risk stratification at diagnosis and time of treatment of patients with chronic lymphocytic leukemia. Curr Opin Hematol. 2006;13:266-272
5. Madewell BR. Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma. J Vet Intern Med. 2004;18:595-596
6. Di RF, Giustolisi R, Lerner S, Cacciola E, O'Brien S, Kantarjian H, et al. Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine. Ann Oncol. 2001;12:621-625
7. Schwartz MK. Enzymes as prognostic markers and therapeutic indicators in patients with cancer. Clin Chim Acta. 1992;206:77-82.
8. O'Neill KL, Zhang F, Li H, Fuja DG, Murray BK. Thymidine kinase 1-a prognostic and diagnostic indicator in ALL and AML patients. Leukemia. 2007;21:560-563
9. Zhang J, Jia Q, Zou S, Zhang P, Zhang X, Skog S, et al. Thymidine kinase 1: a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients. Oncol Rep. 2006;15:455-461
10. Fujiwaki R, Hata K, Moriyama M, Iwanari O, Katabuchi H, Okamura H, et al. Clinical value of thymidine kinase in patients with cervical carcinoma. Oncology. 2001;61:47-54.
11. Socialstyrelsen. Statistics Health and Diseases 2003:6, Cancer incidence in Sweden. http://www.socialstyrelsen.se/NR/rdonlyres/8D37532A-BC53-4B38-9F06- 73CD8BC5AD62/967/2003426.pdf
12. Cancer incidence in five continents. Volume VIII. IARC Sci Publ. 2002:1-781.
13. Rosén M, Lundin A, Nyström L, Rutqvist L, Stenbeck M, Talbäck M. Incidens och dö dlighet i bröstcancer under 25 år. Internationella och regionala jämfö relser. Läkartidningen. 2000;97:294-299
14. Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20- 69 years. Lancet. 2000;355:1822.
15. Dobrovolsky VN, Bucci T, Heflich RH, Desjardins J, Richardson FC. Mice deficient for cytosolic thymidine kinase gene develop fatal kidney disease. Mol Genet Metab. 2003;78:1-10.
16. Bello LJ. Regulation of thymidine kinase synthesis in human cells. Exp Cell Res. 1974;89:263-274
17. Chang ZF, Huang DY, Lai TC. Different regulation of the human thymidine kinase promotor in normal human diploid IMR-90 fibroblasts and HeLa cells. J Biol Chem. 1995;270:27374-27379
18. Munch-Petersen B, Cloos L, Jensen HK, Tyrsted G, Human thymidine kinase 1. Regulation in normal and malignant cells. Adv Enzyme Regul. 1995;35:69-89.
19. Roehl HH, Conrad SE. Identification of a G1-S-phaseregulated region in the human thymidine kinase gene promotor. Mol Cell Biol. 1990;10:3834-3837
20. Käpyaho K, Tanner P, Weber T. Effect of complement binding on a solid-phase immunometric TSH essay. Scand J Clin Lab Invest. 1989;49:211-215
21. Carlander D, Larsson A. Avian antibodies can eliminate interference due to complement activation in ELISA. Ups J Med Sci. 2001;106:189-195
22. Larsson A, Karlsson-Parra A, Sjoquist J. Use of chicken antibodies in enzyme immunoassays to avoid interference by rheumatoid factors. Clin Chem. 1991;37:411-414
23. Larsson A, Sjoquist J. Chicken IgY: utilizing the evolutionary difference. Comp Immunol Microbiol Infect Dis. 1990;13:199-201.
24. Larsson A, Mellstedt H. Chicken antibodies: a tool to avoid interference by human anti-mouse antibodies n ELISA after in vivo treatment with murine menoclonal antibodies. Hybridoma. 1992;11:33-39